FOLLOW US

Endocrinology News and Research Articles

Liraglutide Cuts Risk of Cardiovascular Deaths
06/12/2016 - Liraglutide (Victoza), a drug used to help control blood sugar levels in type 2 diabetes, also reduces the risk of dying from heart disease, new research suggests.
Silent Heart Attacks and Type 2 Diabetes
05/31/2016 - When researchers from Wake Forest Baptist Medical Center in Winston-Salem, North Carolina, checked the hearts and medical records of 9,498 people over nine years, they found nearly equal numbers of untreated, silent heart attacks and recognized heart attacks that had received medical attention.
Targeting Brain Signaling Can Reduce Blood Glucose in Diabetic Mice
05/22/2016 - An animal study found that injecting a hormone directly into the brain of rodents put type 2 diabetes in remission for several months, reports the journal Nature Medicine. 
Skip the Fake Sugars While Pregnant
05/16/2016 - A new study published in JAMA Pediatrics found that babies of women who drank artificially-sweetened beverages while pregnant were 10 percent more likely to be overweight by their first birthday. 
Cholesterol-Lowering Statins Cut Risk for Amputations
05/05/2016 - People with peripheral artery disease (PAD) – including many with diabetes – who took cholesterol-lowering statin drugs had a 22-33 percent lower risk of losing a leg or other limb to amputation in a new Emory University study.
Healthful Diet Staves Off Hypertension in Women with a History of Gestational Diabetes
05/04/2016 - Women who have had pregnancy-related diabetes may be able to reduce their future risk of hypertension by maintaining a healthful diet, shows new research published in the journal Hypertension. 
Weight Loss Drug Slashes Prediabetes Risk
04/24/2016 - A higher-dose version of a diabetes medication liraglutide improves weight loss and reverses prediabetes in a new study. 
Common Thyroid Tumor Downgraded to Non-Cancerous
04/19/2016 - An international panel of pathologists and clinicians has decided to rename a type of thyroid tumor—until now deemed malignant—as non-cancerous.
Dexcom Recall of Continuous Glucose Monitor Receivers
04/17/2016 - Dexcom, Inc., one of the largest makers of continuous glucose monitoring systems (CGMs) in the U.S. is recalling receivers for its G4 Platinum and G5 Mobile CGM systems because of consumer complaints that alarms for low and high blood sugar levels may not sound.
Endocrine Society Warns Against Use of Custom Compounded Bioidentical Hormones
04/06/2016 - Doctors should avoid prescribing compounded hormone medications to treat menopausal symptoms, female sexual dysfunction and other hormonal conditions, according to a recent scientific statement by the Endocrine Society.   
Diabetes Drug Increases Bladder Cancer, Study Shows
04/05/2016 - A new study reveals strong evidence that pioglitazone does in fact increase the risk of bladder cancer, and that the increased risk can occur as quickly as about 22 months on the drug. 
Out-of-Pocket Spending on Insulin Tripled in 11 Years
04/04/2016 - People with type 2 diabetes who use insulin saw out-of-pocket expenses triple between 2002 and 2013, according to a new study published in the Journal of the American Medical Association. 
America’s First Biosimilar Insulin: Coming to Your Drugstore
03/31/2016 - The first biosimilar, a less expensive copy of the popular, long-acting brand-name drug Lantus, is set to hit U.S. pharmacy shelves later this year.
Excess Leptin in Obese Pregnant Women May Cause Type 2 Diabetes in Children
03/28/2016 - Having an excess of the hormone leptin while pregnant could be one of the reasons why children born to obese women are at a higher risk of type 2 diabetes, cites a new study in the journal Cell Reports.
For Best Thyroid Surgery Results, Pick Doctor With 25-Plus Cases a Year
03/21/2016 - Patients who need to have their thyroid gland removed, due to cancer or other conditions, should seek out a surgeon who performs more than 25 such operations each year, according to new research.  
Long-Term Metformin Use Linked with Vitamin B12 Deficiency
03/15/2016 - Long-term use of the popular diabetes drug metformin is linked with vitamin B12 deficiency and anemia, according to new research that solidifies some previous research.
Being Obese Can Lead to Weak Bones
03/13/2016 - A new study published in the journal Metabolism found that obesity and type 2 diabetes led to weakened bones. 
Diabetes Treatment May Increase Breast Density
03/11/2016 - Women on insulin tended to have higher breast density, a risk factor for breast cancer, than those on metformin or dietary control.  
Exercise Reduces Hot Flashes and Other Menopause Symptoms
03/04/2016 - Leading a sedentary life is linked to more severe hot flashes and other menopausal symptoms, according to a new study that surveyed women in Central and South America.
Blood Pressure Medicine May Treat Diabetes, Too
02/18/2016 - The blood pressure-lowering medicine verapamil may also help lower blood sugar levels in those with diabetes, cites new research published in the journal Diabetes Research and Clinical Practice. 
Diabetes Diagnosis of the Future: 11 Types?
02/08/2016 - Diabetes researchers propose a new way to classify high blood sugar problems based on 11 factors that threaten insulin-producing beta cells in the pancreas.
Women's Sleep Problems Up Diabetes Risk
02/05/2016 - Women who have sleep problems such as insomnia have a higher risk of developing type 2 diabetes, finds research in the journal Diabetologia.
Diabetes, Obesity During Pregnancy May Up Autism Risk
02/02/2016 - The risk of autism may increase substantially for children born to mothers with diabetes who are also obese, says new research published in the journal Pediatrics. 
A New Gut Bug Threat Menaces the Brain, Kidneys and Heart
02/01/2016 - An artery-damaging compound linked with higher risk for atherosclerosis and heart attacks –trimethylamine N-oxide (TMAO)—also increases risk for heart failure, kidney failure and strokes, according to a string of recent research from the Cleveland Clinic.
New Diabetes App Can Predict Danger Hours Ahead
01/28/2016 - Medtronic, maker of insulin pumps and continuous glucose monitoring systems, has teamed up with IBM and its supercomputer, Watson, to develop an app usable on smart phones that can predict a potential problem hours before it's reality.

Don't Miss Out! Get the FREE EndocrineWeb eNewsletter!

Sign up to receive treatment and research updates, news, and helpful tips on managing your condition.
Enter email
Submit
close X
SHOW MAIN MENU
SHOW SUB MENU